AACR logo

More articles from Clinical Trials of Cancer Immunotherapies: Poster Presentations - Proffered Abstracts

Abstract A035: Pharmacokinetics and pharmacodynamics of the immunotherapeutic TLR-9 agonist MGN1703 – conclusions by comparison of data from clinical trials with healthy volunteers and cancer patients
Manuel Schmidt, Kerstin Kapp, Detlef Oswald, Matthias Schroff, Burghardt Wittig, Alfredo Zurlo

Cancer Immunology Research Jan 2016, 4 (1 Supplement) A035; DOI: 10.1158/2326-6074.CRICIMTEATIAACR15-A035
Abstract A030: Epigenetic immune modulation by entinostat in breast cancer: Correlative analysis of ENCORE 301 trial
Peter Ordentlich, Min-Jung Lee, Yusuke Tomita, Sunmin Lee, Saori Tomita, Scott Cruickshank, Saranya Chumsri, Jane B. Trepel

Cancer Immunology Research Jan 2016, 4 (1 Supplement) A030; DOI: 10.1158/2326-6074.CRICIMTEATIAACR15-A030
Abstract A047: Safety and clinical activity of durvalumab (MEDI4736), an anti-programmed cell death ligand-1 (PD-L1) antibody, in patients with non-small cell lung cancer (NSCLC)
Scott Antonia, Naiyer Rizvi, Julie Brahmer, Sai-Hong Ou, Samir N. Khleif, Wen-Jen Hwu, Martin Gutierrez, Patrick Schoffski, Omid Hamid, Jared Weiss, Jose Lutzky, Michele Maio, John Nemunaitis, Dirk Jaeger, Ani Balmanoukian, Marlon C. Rebelatto, Keith E. Steele, Xiaoping Jin, Paul B. Robbins, John A. Blake-Haskins, Neil H. Segal

Cancer Immunology Research Jan 2016, 4 (1 Supplement) A047; DOI: 10.1158/2326-6074.CRICIMTEATIAACR15-A047
Abstract A046: Phase 2 study to evaluate the clinical efficacy and safety of MEDI4736 in patients with glioblastoma (GBM)
David A. Reardon, Jorg Dietrich, Thomas Kaley, Hui Gan, Gavin P. Dunn, Timothy Cloughesy, Michael Lim, Jennifer Clarke, Andrew Park, Linda Pan, Domenic W. Lai, Joyson Karakunnel, Paul Robbins, Rajesh Narwal, Ralph Venhaus

Cancer Immunology Research Jan 2016, 4 (1 Supplement) A046; DOI: 10.1158/2326-6074.CRICIMTEATIAACR15-A046
Abstract A042: A predictive nomogram to determine CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy
Amani Makkouk, Cariad Chester, Serena Chang, Vandana Sundaram, Manisha Desai, Inna Sayfer, Holden T. Maecker, Holbrook E. Kohrt

Cancer Immunology Research Jan 2016, 4 (1 Supplement) A042; DOI: 10.1158/2326-6074.CRICIMTEATIAACR15-A042
Abstract A050: Local administration of CpG-B increases recurrence-free survival in early-stage melanoma patients: Long-term follow-up of two randomized clinical trials evaluating adjuvant treatment
Tanja D. de Gruijl, Bas D. Koster, Mari F.C.M. van den Hout, Berbel J.R. Sluijter, Barbara G. Molenkamp, Paul A.M. van Leeuwen, Rik J. Scheper, M. Petrousjka van den Tol, Alfons J.M. van den Eertwegh

Cancer Immunology Research Jan 2016, 4 (1 Supplement) A050; DOI: 10.1158/2326-6074.CRICIMTEATIAACR15-A050
Abstract A045: Dendritic cell vaccination with partial Treg depletion in relapsed glioblastoma – results from the pilot phase of the HIT-HGG Rez Immunvac study
Matthias Eyrich, Jürgen Krauss, Mario Löhr, Antje Technau, Johannes Rachor, Camelia Monoranu, Monika Warmuth-Metz, Matthias Wölfl, Christof Kramm, Paul Gerhardt Schlegel

Cancer Immunology Research Jan 2016, 4 (1 Supplement) A045; DOI: 10.1158/2326-6074.CRICIMTEATIAACR15-A045
Abstract A031: CD8+T cells fail to form an effector memory in glioblastoma patients treated with dendritic cell immunotherapy in combination with chemotherapy
Serena Pellegatta, Marica Eoli, Elena Anghileri, Sara Pessina, Carlo Antozzi, Simona Frigerio, Gabriele Cantini, Maria Grazia Bruzzone, Bianca Pollo, Eugenio A. Parati, Gaetano Finocchiaro

Cancer Immunology Research Jan 2016, 4 (1 Supplement) A031; DOI: 10.1158/2326-6074.CRICIMTEATIAACR15-A031
Abstract A048: Phase 1 clinical trial of a therapeutic prostate cancer vaccine containing PSA/IL-2/GM-CSF in PSA defined biochemical recurrent prostate cancer patients
Jonathan F. Head, Gregory A. Daniels, Michelle McKinney, Weg Ongkeko, Jessica Wang-Rodriguez, Kyoko Sakamoto, Robert L. Elliott

Cancer Immunology Research Jan 2016, 4 (1 Supplement) A048; DOI: 10.1158/2326-6074.CRICIMTEATIAACR15-A048
Abstract A038: The feasibility of inducing effective systemic immune responses to human metastatic melanoma with intralesional secreted cytokines
Fred T. Valentine, Frederick M. Golomb, Matthew Haris, Daniel F. Roses

Cancer Immunology Research Jan 2016, 4 (1 Supplement) A038; DOI: 10.1158/2326-6074.CRICIMTEATIAACR15-A038

Main menu

User menu

Search

More articles from Clinical Trials of Cancer Immunotherapies: Poster Presentations - Proffered Abstracts

Pages

Articles

Info for

About Cancer Immunology Research